EDITORIAL: BRAIN CYTOPROTECTION FOR REPERFUSION INJURY AFTER ACUTE ISCHEMIC STROKE - Report - MDSpire

EDITORIAL: BRAIN CYTOPROTECTION FOR REPERFUSION INJURY AFTER ACUTE ISCHEMIC STROKE

  • By

  • Tang, Lujia

  • Zhao, Zilong

  • Zhao, Wenbo

  • IKKA, Léon

  • Liu, Shuling

  • Wei, Ming

  • June 8, 2026

  • 0 min

Share

Clinical Report: Protecting Brain Cells from Reperfusion Damage Following Acute Ischemic Stroke

Overview

Acute ischemic stroke (AIS) is a major cause of mortality and disability, with reperfusion therapies improving outcomes but often leading to reperfusion injury.

Background

Acute ischemic stroke remains a leading cause of death and long-term disability globally. Despite advancements in reperfusion therapies, many patients experience limited recovery due to reperfusion injury, which involves a complex cascade of biological processes.

Data Highlights

No numerical data available in the source material.

Key Findings

  • Reperfusion injury is a complex process involving excitotoxicity, oxidative stress, and neuroinflammation.
  • Outcomes after successful recanalization can vary significantly among patients.
  • Reperfusion is a biological intervention that can have undesirable consequences.

Clinical Implications

Clinicians should consider brain cytoprotection as integral to the management of acute ischemic stroke.

Conclusion

Improving outcomes after acute ischemic stroke requires a comprehensive approach that includes neuroprotection.

Related Resources & Content

  1. Basic Research in Cardiology, 2018 -- The 10th Biennial Hatter Cardiovascular Institute Workshop: Exploring Cellular Protection Strategies in Myocardial Infarction, Ischemic Stroke, and Cardio-Oncology
  2. Acta Neuropathologica, 2018 -- Inflammation Following Stroke: A Potential Therapeutic Target or a Beneficial Mechanism?
  3. Frontiers in Neurology, 2026 -- Editorial: The regeneration and intervention of neurological tissue after acute and chronic injuries: from benchside to bedside
  4. Frontiers in Neurology, 2026 -- Activin A Mitigates Ferroptosis in Cerebral Ischemia/Reperfusion Injury via the PGC-1α/NRF1/TFAM Axis
  5. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke - Professional Heart Daily | American Heart Association
  6. Adjunctive Intra-Arterial Alteplase After Successful Thrombectomy for Acute Ischemic Stroke: The CHOICE-2 Randomized Clinical Trial - PubMed
  7. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke - Professional Heart Daily | American Heart Association
  8. Adjunctive Intra-Arterial Alteplase After Successful Thrombectomy for Acute Ischemic Stroke: The CHOICE-2 Randomized Clinical Trial - PubMed

Original Source(s)

Related Content